This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Altuwaijri, S. Articles by Chang, C. Search for Related Content PubMed PubMed Citation Articles by Altuwaijri, S. Articles by Chang, C.

Interruption of Nuclear Factor B Signaling by the Androgen Receptor Facilitates 12-O-Tetradecanoylphorbolacetate-Induced Apoptosis in Androgen-sensitive Prostate Cancer LNCaP Cells

George Whipple Laboratory for Cancer Research, Departments of Pathology, Urology, and Radiation Oncology, University of Rochester Medical Center, Rochester, New York 14642 [S. A., H-K. L., K-H. C., S. Y., W-J. L., L. A. H., M. M. R., L. Y., Y. Z., C. C.], and Graduate Institute of Clinical Medical Sciences and Center for Menopause and Reproductive Medicine Research, Chang Gung University, Taiwan 833, Republic of China [H-Y. K., M-Y. T.]

12-O-tetradecanoylphorbolacetate (TPA) influences proliferation, differentiation, and apoptosis in a variety of cells including prostate cancer cells. Here, we show that androgen treatment potentiates TPA-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells but not in androgen-independent prostate cancer cell lines DU145 and PC-3. The use of the antiandrogen bicalutamide (Casodex) rescued LNCaP cells from 5--dihydrotestosterone (DHT)/TPA-induced apoptosis, suggesting that DHT/TPA-induced apoptosis is mediated by androgen/androgen receptor (AR). In addition, a caspase-3 inhibitor (Ac-DEVD-CHO) reduced the level of apoptosis, suggesting that DHT/TPA-mediated apoptosis occurs through a caspase-3-dependent pathway. A functional reporter assay using nuclear factor (NF) B-luciferase and an electromobility gel shift assay showed that DHT suppressed NFB activity. In addition, apoptosis mediated by combined DHT/TPA treatment was abrogated by overexpression of the NFB subunit p65 in LNCaP-p65 cells, suggesting that NFB may play an important role in regulating the effects of androgen/AR and TPA on apoptosis. Furthermore, use of the c-Jun N-terminal kinase (JNK) inhibitor SB202190 showed that the combination of DHT/TPA increased JNK activation in LNCaP cells but not in LNCaP-p65 cells, demonstrating that NFB may be able to suppress JNK activity. These results indicate that androgen/AR facilitates TPA-induced apoptosis by interruption of the NFB signaling pathway, leading to activation of JNK in LNCaP cells. These data describe a signaling pathway that could potentially be useful in proposed therapeutic treatment strategies exploiting combinations of different agents that control apoptosis in prostate tumors.

This article has been cited by other articles:

				X. Zhang, W. Li, and A. F. Olumi Low-Dose 12-O-Tetradecanoylphorbol-13-Acetate Enhances Tumor Necrosis Factor Related Apoptosis-Inducing Ligand Induced Apoptosis in Prostate Cancer Cells Clin. Cancer Res., December 1, 2007; 13(23): 7181 - 7190. [Abstract] [Full Text] [PDF]

				B. Peant, J.-S. Diallo, L. Lessard, N. Delvoye, C. Le Page, F. Saad, and A.-M. Mes-Masson Regulation of I{kappa}B Kinase {varepsilon} Expression by the Androgen Receptor and the Nuclear Factor-{kappa}B Transcription Factor in Prostate Cancer Mol. Cancer Res., January 1, 2007; 5(1): 87 - 94. [Abstract] [Full Text] [PDF]

				X. Zheng, R. L. Chang, X.-X. Cui, G. E. Avila, V. Hebbar, M. Garzotto, W. J. Shih, Y. Lin, S.-E. Lu, A. B. Rabson, et al. Effects of 12-O-Tetradecanoylphorbol-13-acetate (TPA) in Combination with Paclitaxel (Taxol) on Prostate Cancer LNCaP Cells Cultured In vitro or Grown as Xenograft Tumors in Immunodeficient Mice. Clin. Cancer Res., June 1, 2006; 12(11): 3444 - 3451. [Abstract] [Full Text] [PDF]

				A. M. Gonzalez-Guerrico and M. G. Kazanietz Phorbol Ester-induced Apoptosis in Prostate Cancer Cells via Autocrine Activation of the Extrinsic Apoptotic Cascade: A KEY ROLE FOR PROTEIN KINASE C{delta} J. Biol. Chem., November 25, 2005; 280(47): 38982 - 38991. [Abstract] [Full Text] [PDF]

				E. K. Go, K. J. Jung, J. Y. Kim, B. P. Yu, and H. Y. Chung Betaine Suppresses Proinflammatory Signaling During Aging: The Involvement of Nuclear Factor-{kappa}B via Nuclear Factor-Inducing Kinase/I{kappa}B Kinase and Mitogen-Activated Protein Kinases J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2005; 60(10): 1252 - 1264. [Abstract] [Full Text] [PDF]

				L. Yang, S. Xie, Md. S. Jamaluddin, S. Altuwaijri, J. Ni, E. Kim, Y.-T. Chen, Y.-C. Hu, L. Wang, K.-H. Chuang, et al. Induction of Androgen Receptor Expression by Phosphatidylinositol 3-Kinase/Akt Downstream Substrate, FOXO3a, and Their Roles in Apoptosis of LNCaP Prostate Cancer Cells J. Biol. Chem., September 30, 2005; 280(39): 33558 - 33565. [Abstract] [Full Text] [PDF]

				N. Gao, Y. Dai, M. Rahmani, P. Dent, and S. Grant Contribution of Disruption of the Nuclear Factor-{kappa}B Pathway to Induction of Apoptosis in Human Leukemia Cells by Histone Deacetylase Inhibitors and Flavopiridol Mol. Pharmacol., October 1, 2004; 66(4): 956 - 963. [Abstract] [Full Text] [PDF]